Lilly buys migraine biotech CoLucid, and the drug it outlicensed, for $960M – FierceBiotech | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/18/lilly-buys-migraine-biotech-colucid-and-the-drug-it-outlicensed-for-960m-fiercebiotech/

FierceBiotechLilly buys migraine biotech CoLucid, and the drug it outlicensed, for $960MFierceBiotechLilly will spend nearly $1 billion to buy the company it outlicensed the migraine med to back in 2005. Share Facebook Twitter LinkedIn Email Print. Eli Lilly says it will spend nearly $1 billion to buy out CoLucid Pharmaceuticals … http://internationalnewslive.com/lilly-buys-migraine-biotech-colucid-and-the-drug-it-outlicensed-for-960m-fiercebiotech/